# Vericel Corporation (VCEL)

> Vericel Corporation (VCEL) trades at $54.62 (+5.49%) as of 7:30:03 PM EST on Nov 6, 2026, +36.38% over the past month. Market cap is $2.65B, with 9.5 days to cover in short interest.

Canonical: https://massive.com/quote/vcel
Data as of: 2026-11-07T00:30:03.537Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$54.62** +2.84 (+5.49%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$56.32** +1.70 (+3.11%)
As of 7:30:03 PM EST on Nov 6, 2026 · After hours

## Stock performance

How Vericel Corporation (VCEL) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +5.48% |
| 1W | +35.67% |
| 1M | +36.38% |
| YTD | +51.68% |
| 1Y | +40.09% |
| 52-wk range | $28.95 – $55.60 |

From daily closes through Nov 6, 2026.

## Key statistics

Today's trading snapshot for VCEL: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $50.76 – $54.64 |
| Open | $51.79 |
| Prev close | $51.78 |
| Volume | 1.62M |
| Market cap | $2.65B |
| Shares out | 51.21M |

## Valuation and profitability ratios

Valuation and profitability ratios for Vericel Corporation: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | 109.47 |
| P/S | 8.66 |
| P/B | 7.17 |
| P/FCF | 43.00 |
| ROE | 6.6% |
| ROA | 4.8% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 5, 2026

## Insider trading

[Vericel Corporation (VCEL) insider trading](https://massive.com/quote/vcel/insider-trading.md): open-market Form 4 buys and sells by Vericel Corporation insiders over the last 12 months.

## 8-K filings

Material corporate events Vericel Corporation has disclosed to the SEC on Form 8-K.

- Nov 5, 2026 · [Guidance issuance or update](https://massive.com/quote/sec-filings/8-k/guidance-updates.md)
  “Exhibit 99.1 is described as the press release of Vericel Corporation, "Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial Guidance."”
- Jul 30, 2026 · [Guidance issuance or update](https://massive.com/quote/sec-filings/8-k/guidance-updates.md)
  “Press Release of Vericel Corporation, 'Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program'”
- May 18, 2026 · Bylaw amendment
  “Effective May 18, 2026, the Board of Directors of Vericel Corporation, a Michigan corporation (the "Company"), approved an amendment to the Company's bylaws. The amendment accounts for the change in the address of the Company's principal executive offices as a result of its move to a new global headquarters, located at 25 Blue Sky Drive, Burlington, Massachusetts 01803.”
- May 7, 2026 · [Guidance issuance or update](https://massive.com/quote/sec-filings/8-k/guidance-updates.md)
  “Press Release of Vericel Corporation, 'Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance'”
- Jan 13, 2026 · [Preliminary results](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “the Company issued a press release, which includes estimates of operating and financial results, including its estimated, preliminary and unaudited full-year revenue for fiscal year 2025, preliminary and unaudited net income for 2025, preliminary and unaudited 2025 gross margin percentage, preliminary 2025 adjusted EBITDA margin, its estimated cash and investments balance as of December 31, 2025”

## Dividend history and stock splits

Vericel Corporation's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-20 · Oct 16, 2013

## VCEL short interest

How heavily VCEL is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 9.5 |
| Short interest | 5.24M |
| Avg volume | 550.01K |

As of Oct 15, 2026 · reported to FINRA twice monthly.

## VCEL news

The latest news and headlines about Vericel Corporation (VCEL).

- [Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program](https://www.globenewswire.com/news-release/2026/07/30/3335958/34447/en/Vericel-Reports-Second-Quarter-2026-Financial-Results-Raises-Full-Year-Financial-Guidance-and-Announces-Share-Repurchase-Program.html) · GlobeNewswire Inc. · Jul 30, 2026 · positive sentiment
- [Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations \| DelveInsight](https://www.globenewswire.com/news-release/2026/05/05/3288098/0/en/Global-Stem-Cell-Therapy-Market-Set-to-Flourish-at-a-CAGR-of-11-by-2034-Owing-to-the-Technological-Advancements-and-Favorable-Regulations-DelveInsight.html) · GlobeNewswire Inc. · May 5, 2026 · positive sentiment
- [Vericel Announces Preliminary 2025 Financial Results and Business Updates](https://www.globenewswire.com/news-release/2026/01/13/3217833/34447/en/Vericel-Announces-Preliminary-2025-Financial-Results-and-Business-Updates.html) · GlobeNewswire Inc. · Jan 13, 2026 · positive sentiment
- [Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings](https://www.fool.com/coverage/filings/2025/11/06/brown-capital-discloses-usd31-million-sale-of-vericel-stock-as-small-cap-biotech-reports-earnings/?source=iedfolrf0000001) · The Motley Fool · Nov 6, 2025 · neutral sentiment
- [MediWound Revenue Jumps 43% in Q2](https://www.fool.com/data-news/2025/08/14/mediwound-revenue-jumps-43-percent-in-q2/?source=iedfolrf0000001) · The Motley Fool · Aug 14, 2025 · positive sentiment

## About Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 398 |
| Listed | Feb 4, 1997 |

[Company website](https://www.vcel.com)

## FAQ

### What is the Vericel Corporation (VCEL) stock price today?

Vericel Corporation (VCEL) is trading at $54.62 (+5.49% on the day) as of 7:30:03 PM EST on Nov 6, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Vericel Corporation?

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen…

### What is the short interest in VCEL?

As of Oct 15, 2026, VCEL has 5.24M shares short and 9.5 days to cover.

### What exchange is VCEL listed on?

Vericel Corporation (VCEL) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.

## Live data

Prices here are 15-minute delayed. For real-time VCEL quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=VCEL`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Vericel Corporation (VCEL) insider trading](https://massive.com/quote/vcel/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms